A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-011 in Patients With Advanced Solid Tumor (NCT04906434)

🧪 Interventions in This Study

• ABSK-011 (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (32 Sites)

Showing the first 25 of 32 sites.

• Mayo Clinic — Phoenix, Arizona
• Mayo Clinic — Jacksonville, Florida
• Moffitt Cancer Center — Tampa, Florida
• Mayo Clinic — Rochester, Minnesota
• Icahn School of Medicine at Mount Sinai — New York, New York
• MD Anderson Cancer Center — Houston, Texas
• The First Affiliated Hospital of Bengbu Medical College — Bengbu, Anhui
• Beijing Tsinghua Changgung Hospital — Beijing, Beijing Municipality
• The Fifth Medical Center of the General Hospital of the Chinese People's Liberation Army — Beijing, Beijing Municipality
• Chongqing Cancer Hospital — Chongqing, Chongqing Municipality
• Fujian Provincial Cancer Hospital — Fuzhou, Fujian
• Sun Yat Sen Memorial Hospital — Guangzhou, Guangdong
• Guangxi Zhuang Autonomous Region People's Hospital — Nanning, Guangxi
• Weifang People's Hospital — Weifang, Hebei
• Harbin Medical University Cancer Hospital — Haerbin, Heilongjiang
• First Affiliated Hospital of Henan University of Science and Technology — Luoyang, Henan
• Henan Cancer Hospital — Zhengzhou, Henan
• Hubei Cancer Hospital — Wuhan, Hubei
• Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology — Wuhan, Hubei
• Hunan Cancer Hospital — Changsha, Hunan
• Hunan Provincial People's Hospital — Changsha, Hunan
• Suzhou University Affiliated Second Hospital — Suzhou, Jiangsu
• Tonghua Central Hospital — Tonghua, Jilin
• Shengjing Hospital of China medical university — Shenyang, Liaoning
• General Hospital of Ningxia Medical University — Yinchuan, Ningxia

📞 Contact the Study Coordinator

Phone: +86021-68910052

Email: clinical@abbisko.cn

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

Explore by condition: All Advanced Liver Cancer clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.